192 related articles for article (PubMed ID: 21725573)
1. Metal-based antitumour drugs in the post-genomic era: what comes next?
Sava G; Bergamo A; Dyson PJ
Dalton Trans; 2011 Sep; 40(36):9069-75. PubMed ID: 21725573
[TBL] [Abstract][Full Text] [Related]
2. Metal-based antitumour drugs in the post genomic era.
Dyson PJ; Sava G
Dalton Trans; 2006 Apr; (16):1929-33. PubMed ID: 16609762
[TBL] [Abstract][Full Text] [Related]
3. A categorization of metal anticancer compounds based on their mode of action.
Gianferrara T; Bratsos I; Alessio E
Dalton Trans; 2009 Oct; (37):7588-98. PubMed ID: 19759927
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs.
Sava G; Jaouen G; Hillard EA; Bergamo A
Dalton Trans; 2012 Jul; 41(27):8226-34. PubMed ID: 22614531
[TBL] [Abstract][Full Text] [Related]
5. Metals and metal derivatives in medicine.
Colotti G; Ilari A; Boffi A; Morea V
Mini Rev Med Chem; 2013 Feb; 13(2):211-21. PubMed ID: 23438056
[TBL] [Abstract][Full Text] [Related]
6. Metal based drugs: from serendipity to design.
Fricker SP
Dalton Trans; 2007 Nov; (43):4903-17. PubMed ID: 17992275
[TBL] [Abstract][Full Text] [Related]
7. Copper, gold and silver compounds as potential new anti-tumor metallodrugs.
Tan SJ; Yan YK; Lee PP; Lim KH
Future Med Chem; 2010 Oct; 2(10):1591-608. PubMed ID: 21426151
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs.
Bergamo A; Sava G
Dalton Trans; 2011 Aug; 40(31):7817-23. PubMed ID: 21629963
[TBL] [Abstract][Full Text] [Related]
9. Chemistry. Metal-based therapeutics.
Hambley TW
Science; 2007 Nov; 318(5855):1392-3. PubMed ID: 18048674
[No Abstract] [Full Text] [Related]
10. Recent researches in metal supramolecular complexes as anticancer agents.
Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
Anticancer Agents Med Chem; 2010 Jun; 10(5):371-95. PubMed ID: 20380632
[TBL] [Abstract][Full Text] [Related]
11. Novel metal-based anticancer drugs: a new challenge in drug delivery.
Lainé AL; Passirani C
Curr Opin Pharmacol; 2012 Aug; 12(4):420-6. PubMed ID: 22609113
[TBL] [Abstract][Full Text] [Related]
12. Fast and slow versus strong and weak metal-DNA binding: consequences for anti-cancer activity.
Reedijk J
Metallomics; 2012 Jul; 4(7):628-32. PubMed ID: 22488113
[TBL] [Abstract][Full Text] [Related]
13. Dalton Transactions themed issue on metal anticancer compounds.
Sadler PJ
Dalton Trans; 2009 Dec; (48):10647. PubMed ID: 20023890
[No Abstract] [Full Text] [Related]
14. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
15. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
16. Anticancer metal compounds in NCI's tumor-screening database: putative mode of action.
Huang R; Wallqvist A; Covell DG
Biochem Pharmacol; 2005 Apr; 69(7):1009-39. PubMed ID: 15763539
[TBL] [Abstract][Full Text] [Related]
17. Antitumour drug design: DNA-binding ligands, which inhibit the topoisomerase I.
Pindur U; Lemster T
Pharmazie; 1998 Feb; 53(2):79-86. PubMed ID: 9540103
[TBL] [Abstract][Full Text] [Related]
18. Chirality in metal-based anticancer agents.
Wang Y; Huang H; Zhang Q; Zhang P
Dalton Trans; 2018 Mar; 47(12):4017-4026. PubMed ID: 29479608
[TBL] [Abstract][Full Text] [Related]
19. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
20. An omics perspective to the molecular mechanisms of anticancer metallo-drugs in the computational microscope era.
Spinello A; Magistrato A
Expert Opin Drug Discov; 2017 Aug; 12(8):813-825. PubMed ID: 28604114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
